Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Marchetti

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Blood Transfusion = Trasfusione Del Sangue|April 14, 2020
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)Marco Marietta, Walter Ageno, Andrea Artoni, et al.
American Journal of Hematology|September 7, 2013
Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemiaMarina Marchetti, Carmen J Tartari, Laura Russo, et al.
Cancer Investigation|July 11, 2017
Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous ThromboembolismAndrea D'Alessio, Marina Marchetti, Carmen Julia Tartari, et al.
Haematologica|June 11, 2009
Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemiaMarijke C Trappenburg, Muriel van Schilfgaarde, Marina Marchetti, et al.
Thrombosis Research|June 6, 2013
ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia VeraMarina Panova-Noeva, Marina Marchetti, Laura Russo, et al.
Blood|July 14, 2011
JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patientsMarina Panova-Noeva, Marina Marchetti, Sabrina Buoro, et al.
Blood|September 5, 2008
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia veraMarina Marchetti, Elisabetta Castoldi, Henri M H Spronk, et al.
European Journal of Medical Research|August 31, 2022
Ischemic and hemorrhagic abdominal complications in COVID-19 patients: experience from the first Italian wavePietro Andrea Bonaffini, Paolo Niccolò Franco, Alice Bonanomi, et al.
British Journal of Haematology|October 16, 2019
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool diseaseMaria Adele Alberelli, Monica Bacci, Marina Marchetti, et al.
Blood Transfusion = Trasfusione Del Sangue|March 12, 2015
Evaluation of nucleated red blood cell count by Sysmex XE-2100 in patients with thalassaemia or sickle cell anaemia and in neonatesSabrina Buoro, Mauro Vavassori, Silvia Pipitone, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Blood Transfusion = Trasfusione Del Sangue|April 14, 2020
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)Marco Marietta, Walter Ageno, Andrea Artoni, et al.
American Journal of Hematology|September 7, 2013
Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemiaMarina Marchetti, Carmen J Tartari, Laura Russo, et al.
Cancer Investigation|July 11, 2017
Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous ThromboembolismAndrea D'Alessio, Marina Marchetti, Carmen Julia Tartari, et al.
Haematologica|June 11, 2009
Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemiaMarijke C Trappenburg, Muriel van Schilfgaarde, Marina Marchetti, et al.
Thrombosis Research|June 6, 2013
ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia VeraMarina Panova-Noeva, Marina Marchetti, Laura Russo, et al.
Blood|July 14, 2011
JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patientsMarina Panova-Noeva, Marina Marchetti, Sabrina Buoro, et al.
Blood|September 5, 2008
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia veraMarina Marchetti, Elisabetta Castoldi, Henri M H Spronk, et al.
European Journal of Medical Research|August 31, 2022
Ischemic and hemorrhagic abdominal complications in COVID-19 patients: experience from the first Italian wavePietro Andrea Bonaffini, Paolo Niccolò Franco, Alice Bonanomi, et al.
British Journal of Haematology|October 16, 2019
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool diseaseMaria Adele Alberelli, Monica Bacci, Marina Marchetti, et al.
Blood Transfusion = Trasfusione Del Sangue|March 12, 2015
Evaluation of nucleated red blood cell count by Sysmex XE-2100 in patients with thalassaemia or sickle cell anaemia and in neonatesSabrina Buoro, Mauro Vavassori, Silvia Pipitone, et al.
Pageof 9